We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.
CEMI

Delisted

CEMI was delisted on the 27th of April, 2023.

Back to rankings

17 hedge funds and large institutions have $4.8M invested in Chembio diagnostics, Inc. in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $4.76M → $4.8M (+$35K)

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
+$195K
2
SIM
Spark Investment Management
New York
+$39.2K
3
U
UBS
Switzerland
+$16.3K
4
TRCT
Tower Research Capital (TRC)
New York
+$6.01K
5
Morgan Stanley
Morgan Stanley
New York
+$4.77K

Top Sellers

Rank Fund Capital Flow
1
GF
Gabelli Funds
New York
-$273K
2
RIG
Roosevelt Investment Group
New York
-$68K
3
EIM
Essex Investment Management
Massachusetts
-$41K
4
Citigroup
Citigroup
New York
-$13K
5
RNS
Robert N. Shapiro
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$2.76M – – –
WA
2
Wasatch Advisors
Utah
$607K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$466K – – –
HP
4
HealthInvest Partners
Sweden
$281K +$295K +83,372 New
SLG
5
Stanley-Laman Group
Pennsylvania
$226K +$237K +67,143 New
DCM
6
DAFNA Capital Management
California
$186K +$195K +55,202 New
PFC
7
Phocas Financial Corp
California
$71K – – –
Creative Planning
8
Creative Planning
Kansas
$63K – – –
FSA
9
Franklin Street Advisors
North Carolina
$37K – – –
SIM
10
Spark Investment Management
New York
$37K +$39.2K +11,100 New
U
11
UBS
Switzerland
$17K +$16.3K +4,624 +921%
Bank of America
12
Bank of America
North Carolina
$16K +$71 +20 +0.4%
BFA
13
BlackRock Fund Advisors
California
$13K +$565 +160 +4%
TRCT
14
Tower Research Capital (TRC)
New York
$7K +$6.01K +1,702 +426%
Morgan Stanley
15
Morgan Stanley
New York
$5K +$4.77K +1,350 New
Wells Fargo
16
Wells Fargo
California
$4K – – –
GF
17
Gabelli Funds
New York
– -$273K -75,000 Closed
RIG
18
Roosevelt Investment Group
New York
– -$68K -18,750 Closed
EIM
19
Essex Investment Management
Massachusetts
– -$41K -11,387 Closed
Citigroup
20
Citigroup
New York
– -$13K -3,571 Closed
RNS
21
Robert N. Shapiro
– -$3K -875 Closed
Deutsche Bank
22
Deutsche Bank
Germany
– +$134 +38 +3,800%

CEMI Hedge Fund Activity: Q4 2013 in Review

17 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2013, worth a combined $4.8M — up 0.73% from $4.76M a quarter earlier.

Fund positioning in CEMI was balanced in Q4 2013: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 0 trimmed.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $195K. The largest seller was Gabelli Funds, exiting entirely with an estimated $273K sold.

  • 17 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $4.8M of Chembio diagnostics, Inc. stock for Q4 2013, up 0.73% quarter-over-quarter.
  • 5 funds opened new Chembio diagnostics, Inc. positions in Q4 2013 and 5 closed out, a net change of 0 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q4 2013 was DAFNA Capital Management, an estimated $195K added.
  • The largest Chembio diagnostics, Inc. seller in Q4 2013 was Gabelli Funds, an estimated $273K sold.

Based on aggregated 13F filings for Q4 2013.